TCL Archive Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease December 28, 2012
TCL Archive Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival December 28, 2012
TCL Archive Coalition Members Urged To Demand Intent Of Congress In Cancer Act Be Recognized March 13, 1981
TCL Archive “Forward Funding” Will Cost NCI $38 Million, 270 Grants, As OMB Legally Impounds FY 1985 Money February 1, 1985
